Clinical Trial Update: A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on the safety and effectiveness of benralizumab for severe uncontrolled asthma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2020-12-16